Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 18.05.2026 RDVY LN IE000K5F6EL4 900,002.00 USD 21,078,586.40 23.421  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 18.05.2026 FGOV LN IE00BKS2X200 108,638.00 GBP 1,601,393.87 16.959  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 18.05.2026 QJUN.LN IE000HFBJ0U0 3,700,002.00 USD 83,221,598.14 22.492  ...

WASHINGTON--(BUSINESS WIRE)--Proxy Foods AI, the enterprise AI platform redefining product development across the global food and beverage industry, today announced a strategic partnership with Aperio Global, an expert in Zero Trust and quantum-resilient security for regulated and critical infrastructure sectors. Together, the companies are launching a next-generation intelligence platform that uses AI to accelerate product formulation, optimize ingredients, and predict performance – engineered...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

PARIS & MANCHESTER, England--(BUSINESS WIRE)--Yourgene Health announces the launch of Yourgene Insight DPYD assay, an assay utilising genetic insights for safer chemotherapy treatments....

DURHAM, N.C.--(BUSINESS WIRE)--Lexitas Pharma Services, a portfolio company of QHP Capital, is pleased to announce the closing of its acquisition of Erie Retina Research—one of the nation’s premier retina research centers led by Dr. David Almeida, MD, MBA, PhD—which will operate as a wholly owned subsidiary of Lexitas. As part of the transaction, Lexitas also acquired CASExERIE, LLC, an ophthalmic innovation hub specializing in advanced research, surgical training, and retina-focused product de...

PORTLAND, Ore.--(BUSINESS WIRE)--Tyfone Named a 2026 Best Place to Work in Fintech...

RALEIGH, N.C.--(BUSINESS WIRE)--Vontier increases its share repurchase authorization to $1.0 billion and intends to deploy a majority of its 2026 adjusted free cash flow to buybacks...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Sypris Solutions, Inc. (Nasdaq/GM: SYPR) today reported financial results for its first quarter ended April 5, 2026. HIGHLIGHTS ───────────────────── Orders for Sypris Electronics increased 28% year-over-year and 269% sequentially, driven by bookings supporting various missile programs, a major defense aviation program and subsea fiber-optic data network systems. Orders for our energy products rose 31% year-over-year and 38% sequentially, reflecting positive de...